1192 related articles for article (PubMed ID: 25543847)
21. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
22. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.
Metwally AA; Blagbrough IS; Mantell JM
Mol Pharm; 2012 Nov; 9(11):3384-95. PubMed ID: 23057412
[TBL] [Abstract][Full Text] [Related]
23. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
24. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors.
Szala S; Missol E; Sochanik A; Strozyk M
Gene Ther; 1996 Nov; 3(11):1026-31. PubMed ID: 9044744
[TBL] [Abstract][Full Text] [Related]
25. Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice.
Hattori Y; Tamaki K; Sakasai S; Ozaki KI; Onishi H
Mol Med Rep; 2020 Nov; 22(5):4183-4196. PubMed ID: 33000194
[TBL] [Abstract][Full Text] [Related]
26. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
27. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
[TBL] [Abstract][Full Text] [Related]
28. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
29. Multicomponent cationic lipid-DNA complex formation: role of lipid mixing.
Caracciolo G; Pozzi D; Amenitsch H; Caminiti R
Langmuir; 2005 Dec; 21(25):11582-7. PubMed ID: 16316084
[TBL] [Abstract][Full Text] [Related]
30. Using disaccharides to enhance in vitro and in vivo transgene expression mediated by a lipid-based gene delivery system.
Tseng WC; Tang CH; Fang TY; Su LY
J Gene Med; 2007 Aug; 9(8):659-67. PubMed ID: 17611953
[TBL] [Abstract][Full Text] [Related]
31. The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency.
Esposito C; Generosi J; Mossa G; Masotti A; Castellano AC
Colloids Surf B Biointerfaces; 2006 Dec; 53(2):187-92. PubMed ID: 17049213
[TBL] [Abstract][Full Text] [Related]
32. Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes.
Birchall JC; Kellaway IW; Mills SN
Int J Pharm; 1999 Jun; 183(2):195-207. PubMed ID: 10361170
[TBL] [Abstract][Full Text] [Related]
33. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
[TBL] [Abstract][Full Text] [Related]
34. Expression of luciferase plasmid (pCMVLuc) entrapped in DPPC/cholesterol/DDAB liposomes in HeLa cell lines.
Manosroi A; Thathang K; Manosroi J; Werner RG; Schubert R; Peschka-Süss R
J Liposome Res; 2009; 19(2):131-40. PubMed ID: 19515000
[TBL] [Abstract][Full Text] [Related]
35. Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies.
McNeil SE; Vangala A; Bramwell VW; Hanson PJ; Perrie Y
Curr Drug Deliv; 2010 Apr; 7(2):175-87. PubMed ID: 20158478
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.
Khatri N; Baradia D; Vhora I; Rathi M; Misra A
AAPS PharmSciTech; 2014 Dec; 15(6):1630-43. PubMed ID: 25145330
[TBL] [Abstract][Full Text] [Related]
37. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
Kapoor M; Burgess DJ
Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
[TBL] [Abstract][Full Text] [Related]
38. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
[TBL] [Abstract][Full Text] [Related]
39. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
[TBL] [Abstract][Full Text] [Related]
40. Effects of sucrose ester structures on liposome-mediated gene delivery.
Zhao Y; Liu A; Du Y; Cao Y; Zhang E; Zhou Q; Hai H; Zhen Y; Zhang S
Acta Biomater; 2018 May; 72():278-286. PubMed ID: 29609051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
